Related Experiment Videos
Design and analysis of an engineered human interleukin-10 monomer
K Josephson1, R DiGiacomo, S R Indelicato
1Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.
The Journal of Biological Chemistry
|May 2, 2000
Summary
Engineered monomeric interleukin 10 (IL-10M1) forms a 1:1 complex with IL-10Ralpha, retaining biological activity for cellular responses. This monomeric form simplifies structure-function studies of IL-10 signaling pathways.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Wild-type human interleukin 10 (wtIL-10) functions as a domain-swapped dimer.
- Understanding IL-10's structure-function relationship requires detailed studies of its receptor interactions.
Purpose of the Study:
- To engineer a monomeric form of human interleukin 10 (IL-10M1) for structure-function analysis.
- To characterize the interaction of IL-10M1 with its soluble receptor alpha subunit (sIL-10Ralpha).
- To assess the biological activity of the IL-10M1 monomer-receptor complex.
Main Methods:
- Protein engineering to create IL-10M1 monomer.
- Characterization using mass spectrometry, size exclusion chromatography, cross-linking, and circular dichroism.
- Isothermal titration calorimetry to analyze binding kinetics and stoichiometry.
Main Results:
- IL-10M1 is a stable, alpha-helical monomer with a structure similar to one domain of wtIL-10.
- IL-10M1 forms a 1:1 complex with sIL-10Ralpha, unlike the 2:4 complex formed by wtIL-10.
- The 1:1 interaction is sufficient for biological activity in cellular proliferation assays.
Conclusions:
- The monomeric IL-10 (IL-10M1) provides a simplified model for studying IL-10 receptor interactions.
- A 1:1 stoichiometry between IL-10M1 and IL-10Ralpha is sufficient for initiating downstream signaling.
- This engineered monomer facilitates detailed investigations into IL-10's mechanism of action.